How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Industrial Isotope Market
- By Isotope Type: Cobalt-60, Iridium-192, Cesium-137, Americium-241, Tritium
- By Application: Radiography and Non-Destructive Testing, Sterilization and Disinfection, Tracer and Measurement Applications, Thickness Gauging, Radiation Therapy Equipment
- By Source Form: Sealed Sources, Unsealed Sources, Encapsulated Sources
- By End-User Industry: Healthcare and Medical, Oil and Gas, Food and Agriculture, Manufacturing and Industrial Processing, Research and Academia
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cobalt-60 leads By Isotope Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.167 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the Industrial Isotope Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Isotope Type 5
Application 5
Source Form 3
End-User Industry 5
Companies profiled
GE Healthcare
Curium Pharma
Nordion (a Sotera Health company)
Lantheus Medical Imaging
MDS Nordion
Isotope Technologies Garching GmbH (ITG)
Advanced Accelerator Applications (a Novartis company)
Eckert & Ziegler AG
Siemens Healthineers
Ion Beam Applications (IBA)
NTP Radioisotopes SOC Ltd
China Isotope & Radiation Corporation (CIRC)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Curium Pharma
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nordion (a Sotera Health company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Lantheus Medical Imaging
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →MDS Nordion
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Isotope Technologies Garching GmbH (ITG)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Advanced Accelerator Applications (a Novartis company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Eckert & Ziegler AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Siemens Healthineers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Ion Beam Applications (IBA)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →NTP Radioisotopes SOC Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →China Isotope & Radiation Corporation (CIRC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Nuclear Energy Corporation of South Africa (Necsa)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BRIT (Board of Radiation and Isotope Technology)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Institute of Isotopes Co. Ltd. (Hungary)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,595M by 2033 · 6.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cobalt-6046.2
- Iridium-19213.9
- Cesium-13715.1
- Americium-24115.5
- Tritium9.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,565M → $2,513M · 6.1%
Europe$1,091M → $1,846M · 6.8%
Asia Pacific$995.7M → $1,665M · 6.6%
Latin America$616.4M → $1,015M · 6.4%
Middle East and Africa$474.1M → $700.9M · 5.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.022026
6.022027
6.052028
6.062029
6.072030
6.082031
6.102032
6.112033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- GE Healthcare15.6
- Curium Pharma14.2
- Nordion (a Sotera Health company)12.0
- Lantheus Medical Imaging8.4
- MDS Nordion11.7
- Isotope Technologies Garching GmbH (ITG)10.2
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Isotope Type18.4%
Application18.9%
Source Form37.2%
End-User Industry25.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.5
- Europe23.9
- Asia Pacific21.5
- Latin America13.1
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| GE Healthcare | 98 | 95 | 88 | 96 | 92 | 87 | 93 |
| Curium Pharma | 68 | 85 | 87 | 86 | 89 | 86 | 84 |
| Nordion (a Sotera Health company) | 84 | 82 | 80 | 75 | 64 | 74 | 77 |
| Lantheus Medical Imaging | 68 | 76 | 64 | 81 | 60 | 63 | 69 |
| MDS Nordion | 74 | 67 | 56 | 62 | 74 | 62 | 66 |
| Isotope Technologies Garching GmbH (ITG) | 69 | 48 | 64 | 48 | 64 | 63 | 59 |
| Advanced Accelerator Applications (a Novartis company) | 58 | 48 | 54 | 41 | 52 | 42 | 49 |
| Eckert & Ziegler AG | 55 | 50 | 55 | 47 | 54 | 43 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- GE Healthcare
- Curium Pharma
- Nordion (a Sotera Health company)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| GE Healthcare | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Curium Pharma | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Nordion (a Sotera Health company) | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| Lantheus Medical Imaging | ◐ | ◐ | ✓ | ✓ | − | ◐ |
| MDS Nordion | ✓ | − | ◐ | ◐ | ✓ | − |
| Isotope Technologies Garching GmbH (ITG) | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Advanced Accelerator Applications (a Novartis company) | ◐ | ◐ | − | − | − | − |
| Eckert & Ziegler AG | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1GE Healthcare93
2Curium Pharma84
3Nordion (a Sotera Health company)77
4Lantheus Medical Imaging69
5MDS Nordion66
6Isotope Technologies Garching GmbH (ITG)59
7Eckert & Ziegler AG51
8Advanced Accelerator Applications (a Novartis company)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
GE HealthcareCurium Pharma
Challenger2
Strong scale, closing on the leaders.
Nordion (a Sotera Health company)Lantheus Medical Imaging
Contender2
Focused players with pockets of strength.
MDS NordionIsotope Technologies Garching GmbH (ITG)
Niche2
Specialists in a single segment or region.
Advanced Accelerator Applications (a Novartis company)Eckert & Ziegler AG
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Isotope Type in North America, then scale across Industrial Isotope Market — a $312M beachhead inside a $5.57B market.
Beachhead (SOM)$312Mobtainable near-term
Serviceable (SAM)$2.00Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Cobalt-60
Best fit — highest urgency & budget in Isotope Type.
Economic buyer80 fit
Iridium-192
Strong fit — clear ROI and a fast path to value.
End user66 fit
Cesium-137
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Isotope Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Source Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Isotope Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Industrial Isotope Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified21%
Evaluation12%
Closed-won5%
$9.3KCAC
$53KLTV
5.7:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Industrial Isotope Market is a durable-growth opportunity — $5.70B by 2033, compounding at 6.4%.
TAM · 2025$3.46Btoday
TAM · 2033$5.70Bforecast
CAGR6.4%2027–2033
Cumulative$40.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.70BTotal addressable market
SAM$2.02BServiceable available market
SOM$364MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.4% CAGR
Demand compounds through 2033, outpacing GDP across Isotope Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Isotope Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.70BLarge & growingTAM by 2033 at 6.4% CAGR
$2.02BServiceable nowreachable with today’s model
$364MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.44BBear4.2% CAGR
$5.70BBase6.4% CAGR
$7.29BBull8.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Industrial Isotope Market — a $682M market by 2033. Plan: grow share from 7.9% to 17.4%.
Market size · 2033$682Mtotal addressable
Market CAGR4.5%2027–2033
Target share17.4%from 7.9% today
Revenue ambition$119Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 17.4% | At risk |
| Revenue | $58M | $119M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 28.2% | 38.0% | Behind |
| Customer retention | 88.0% | 93.9% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Isotope Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Isotope Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $14M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Isotope Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Industrial Isotope Market conversation — a $7.06B market you can size, segment and defend in minutes.
Market size · 2033$7.06Btotal opportunity
Growth7.2%CAGR to 2033
Addressable buyers1,533+accounts in scope
Typical ROI5.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Isotope Type
Goal Grow share in Isotope Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.2×return on cost, year one
< 3 mopayback period
$50K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
GE HealthcareCurium PharmaNordion (a Sotera Health company)Lantheus Medical ImagingMDS NordionIsotope Technologies Garching GmbH (ITG)Advanced Accelerator Applications (a Novartis company)Eckert & Ziegler AG+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Industrial Isotope Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Industrial Isotope Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Patch Insulin Pumps Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportDental Caries Treatment Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportAnaesthesia Gas Evaporators Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportAbsorbable Nasal Implant Devices Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportGenetic Analyzer Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportArtificial Larynx Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportArtificial Valve Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportSandwich ELISA Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportRSV Diagnostics Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportPoint of Care Testing Market
Market size, share, segmentation and regional forecast.
$787M market · 2025 base year
View reportPoint of Care Testing for Infectious Disease Market
Point of Care Testing for Infectious Disease Market is valued at USD 8.62 Billion in 2025 and i…
$8.6B market · 2025 base year
View reportNon-Absorbable Sutures Market
Market size, share, segmentation and regional forecast.
$828M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.